Lyra Therapeutics
LYRA · NASDAQ
$0.19−$0.16 (−45.71%)TodayMarket closed ·
Prev close $0.35
Who owns LYRA
Largest institutional holders, from their latest 13F filings
The 7 largest institutions hold 7.3% of LYRA’s shares.
- North Bridge Venture Partners6.7%
- Waksal (Harlan W)0.6%
- Sempione SIM SpA0.0%
- Merrifield (C Ann)0.0%
- Next 3 largest institutions0.0%
- All other shareholders92.7%
| Holder | Shares | % of shares |
|---|---|---|
| North Bridge Venture Partners | 117.77K | 6.65% |
| Waksal (Harlan W) | 10.74K | 0.61% |
| Sempione SIM SpA | 600 | 0.03% |
| Merrifield (C Ann) | 227 | 0.01% |
| T. Rowe Price Associates, Inc. | 110 | 0.01% |
| Comerica, Inc. | 23 | 0.00% |
| Snyderman (Nancy Lynn) | 21 | 0.00% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Base Investments Sicav - Sempione Smart Equity Fund | 600 | 0.03% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of LYRA in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Smith W Bradford | Other | 640 | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 4.88K
- Days to cover
- 4.10
- % of shares outstanding
- 0.28%
- Average daily volume
- 1.19K
- Change since last report
- −0.3%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.